Thrombophilia: An expanding group of genetic defects that predispose to thrombosis

Molecular Medicine Today

Volumn 3, Issue 7, 1997, Pages 303-309

  Laffan, Michael ^a   Tuddenham, Edward ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING; EVOLUTION; FIBRINOLYSIS; HUMAN; REVIEW; THROMBOPHILIA; THROMBOSIS; VEIN THROMBOSIS;

BLOOD COAGULATION; FEMALE; GENETIC DISEASES, INBORN; HUMANS; MALE; MUTATION; PREGNANCY; THROMBOSIS;

EID: 0031423611     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01064-2     Document Type: Review

References (44)

1. UK health departments (1996) Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-1993, HMS O
2. Lane, D.A. et al. (1996) Inherited thrombophilia: part 1, Thromb. Haemost. 76, 651-662
3. Lane, D.A. et al. (1996) Inherited thrombophilia: part 2, Thromb. Haemost. 76, 824-834
4. Kampe, C.E. (1994) Clinical syndromes associated with lupus anticoagulants, Semin. Thromb. Hemost. 20, 16-26
5. Prandoni, P. et al. (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer, New Engl. J. Med. 327, 1128-1133
6. Olds, R.J. et al. (1994) Antithrombin: the principal inhibitor of thrombin, Semin. Thromb. Hemost. 20, 353-372
7. Bock, S.C., Harris, J.F., Balazs, I. and Trent, J.M. (1985) Assignment of the human antithrombin III structural gene to chromosome 1q23-25, Cytogenet. Cell. Genet. 39, 67-69
8. Rosendaal, F.R. et al. (1991) Mortality in hereditary antithrombin-III deficiency - 1830 to 1989, Lancet 337, 260-262
9. Finazzi, G., Caccia, R. and Barbui, T. (1987) Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases, Thromb. Haemost. 58, 1094
10. Chowdhury, V. et al. (1994) Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis, Thromb. Haemost. 72, 198-202
11. Carrell, R., Skinner, R., Wardell, M. and Whisstock, J. (1995) Antithrombin and heparin, Mol. Med. Today 1, 226-231
12. Lane, D.A. et al. (1992) Pleiotropic effects of antithrombin strand 1C substitution mutations, J. Clin. Invest. 90, 2422-2433
13. Lane, D.A. et al. (1993) Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, Thromb. Haemost. 70, 361-369
14. Patracchini, P. et al. (1989) Sublocalization of the human protein C gene on chromosome 2q13-q14, Hum. Genet. 81, 191-192
15. Reitsma, P.H. et al. (1995) Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on plasma coagulation inhibitors of the Scientific and Standardization Committee of the ISTH, Thromb. Haemost. 73, 876-889
16. Bakker, H.M. et al. (1992) The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C, Eur. J. Biochem. 208, 171-178
17. Zoller, B., Garcia de Frutos, P. and Dahlback, B. (1995) Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease, Blood 85, 3524-3531
18. Simmonds, R.E. et al. Genetic and phenotypic analysis of a large (122 member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes, Blood (in press)
19. Faioni, E.M. et al. (1993) Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay, Thromb. Haemost. 70, 1067-1071
20. Gandrille, S. et al. (1995) Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 85, 130-138
21. Gomez, E., Poort, S.R., Bertina, R.M. and Reitsma, P.H. (1995) Identification of eight point mutations in protein S deficiency type I - analysis of 15 pedigrees, Thromb. Haemost. 73, 750-755
22. Reitsma, P.H., Ploos van Amstel, H. and Bertina, R.M. (1994) Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I, J. Clin. Invest. 93, 486-492
23. Allaart, C.F. et al. (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect, Lancet 341, 134-138
24. Bovill, E.G. et al. (1989) The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73, 712-717
25. Dahlback, B., Carlsson, M. and Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C, Proc. Natl. Acad. Sci. U. S. A. 90, 1004-1008
26. Bertina, R.M. et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature 369, 64-67
27. Takamiya, O., Ishida, F., Kodaira, H. and Kitano, K. (1995) APC-resistance and Mnl I genotype (Gln506) of coagulation factor V are rare in Japanese population, Thromb. Haemost. 74, 996
28. Rees, D.C., Cox, M. and Clegg, J.B. (1995) World distribution of factor V Leiden, Lancet 346, 1133-1134
29. Koster, T. et al. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study, Lancet 342, 1503-1506
30. Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. and Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85, 1504-1508
31. Koster, T. et al. (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis, Lancet 345, 152-155
32. Heijboer, H. et al. (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. New Engl. J. Med. 323, 1512-1516
33. Vandenbroucke, J.P. et al. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation, Lancet 344, 1453-1457
34. Juhan, V.I. et al. (1987) Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis, Thromb. Haemost. 57, 67-72
35. Dawson, S.J. et al. (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells, J. Biol. Chem. 268, 10739-10745
36. Dolan, G., Greaves, M., Cooper, P. and Preston, F.E. (1988) Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds, Br J. Haematol. 70, 417-421
37. Frosst, P. et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nat. Genet. 10, 111-113
38. den Heijer, M. et al. (1995) Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 345, 882-885
39. Poort, S., Rosendaal, F., Reitsma, P. and Bertina, R. (1996) A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood 88, 3698-3703
40. Koeleman, B.P., Reitsma, P.H., Allaart, C.F. and Bertina, R.M. (1994) Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84, 1031-1035
41. Zoller, B., Berntsdotter, A., Garcia de Frutos, P. and Dahlback, B. (1995) Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S, Blood 85, 3518-3523
42. van Boven, H.A. et al. (1996) Factor V Leiden (FVR506Q) in families with inherited antithrombin deficiency, Thromb. Haemost. 75, 417-421
43. Mandel, H. et al. (1996) Coexistence of hereditary homocystinuria and factor V Leiden - effect on thrombosis. New Engl. J. Med. 334, 763-768
44. Bauer, K.A. and Rosenberg, R.D. (1994) Activation markers of coagulation, Bailliere's Clin. Haematol. 7, 523-540